Phase II study of a fixed dose-rate infusion of gemcitabine associated with erlotinib in advanced pancreatic cancer.
Feliu
J
J
Medical Oncology Department, Hospital Universitario La Paz, IDIPAZ, Pº de Castellana 261, 28046 Madrid, Spain. jfeliu.hulp@salud.madrid.org
Borrega
P
P
León
A
A
López-Gómez
L
L
López
M
M
Castro
J
J
Belda-Iniesta
C
C
Barriuso
J
J
Martínez
V
V
González-Barón
M
M